Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(5):409-410; doi:10.1093/jnci/djk080
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Eliassen, A. H.
Right arrow Articles by Hankinson, S. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Eliassen, A. H.
Right arrow Articles by Hankinson, S. E.
Related Collections
Right arrowRelated Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

CORRESPONDENCE

Response: Re: Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer Among Premenopausal Women

A. Heather Eliassen, Robert L. Barbieri, Susan E. Hankinson

Affiliations of authors: Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (AHE, SEH); Department of Epidemiology, Harvard School of Public Health, Boston, MA (AHE, SEH); Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (RLB)

Correspondence to: A. Heather Eliassen, ScD, Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Ave, Boston, MA 02115 (e-mail: heather.eliassen@channing.harvard.edu).

The first 10% of the full text of this article appears below.

We appreciate the comments by Micheli et al. The data they present are intriguing, particularly the stronger association they found between progesterone level and breast cancer risk after further adjustment for luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels. We agree with Micheli et al. that the timing of hormone measurements within the menstrual cycle is . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Correspondence

Re: Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer Among Premenopausal Women
Andrea Micheli, Giorgio Secreto, Elisabetta Meneghini, Vittorio Krogh, Paola Muti, Elisabetta Venturelli, and Franco Berrino
J Natl Cancer Inst 2007 99: 408-409. [Extract] [Full Text] [PDF]